Font Size: a A A
Keyword [KRas]
Result: 181 - 200 | Page: 10 of 10
181. The Efficacy Of First-line Chemotherapy Regimens Combined With Bevacizumab And The Relationship Between The Efficacy And The Status Of RAS And BRAF Genes In Metastatic Colorectal Cancer
182. Clinicopathological Features And Molecular Pathology Of Colorectal Mucinous Adenocarcinoma
183. The Consistency Of Kras Status In Tumor Tissues And Circulating Cell-free Nucleic Acid In Stage ? Colorectal Cancer Patients:A Meta-analysis
184. Variability In HER2 Expression Between Primary Colorectal Cancer And Corresponding Metastases
185. Effects Of Cetuximab Combined With Trametinib On Proliferation And Apoptosis Of Human Colon Cancer Cells
186. Long Non-coding RNA UCA1/KRAS Axis Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth And Stem Cell Properties
187. Establishment Of Pancreatic Cancer Cell Lines Edited With KRAS Gene And Screening Of Potential Therapeutic Targets Based On Crispr/cas9 Technique
188. Expression Levels Of RASSF1A And KRAS In Breast Cancer Tissues And Their Clinical Significance
189. Clinicopathologic Analysis And Differential Diagnosis Of Pulmonary Enteric Adenocarcinoma
190. KRAS Mutation And Protein Levels In-gastric Signet Ringcell Carcinoma Cancer Patients And Response To MEK Inhibitor
191. Combination Of Cetuximab And PP242 Synergistically Suppress The Progression Of Wild-type KRAS Colorectal Carcinoma
192. Computational Screening Deleterious Non-Synonymous Single Nucleotide Polymorphisms And Molecular Dynamic Simulation Of Lung Cancer Associated Mutations In KRAS Gene
193. The Effects Of Mir-490 Family On Biological Behavior Of Bladder Cancer Cell Line EJ And RT4 And Discussing Of Molecular Mechanism
194. The Prognostic Value Of KRAS In Patients With Colorectal Cancer With Unresectable Liver Metastases
195. Characteristics Of KRAS-Specific Mutations In Colorectal Cancer And Its Value In Evaluating Prognosis
196. Survival And Prognosis Of Primary R0 Resected Patients With Lung Metastasis From Colorectal Cancer
197. Screening And Identification Of Single Chain Antibodies To KRAS Protein P.G12S
198. Clinical Study On Combined Detection Of Plasma KRAS, NRAS, BRAF And PIK3CA Genes In Patients With Colorectal Cancer
199. The Function?mechanisms And Clinical Significance Of MicroRNA-30a-5p In Human Colorectal Cancer
200. Multi-omics Integrative Analysis And In Silico Drug Screening In Subtypes Of KRAS-mutant Lung Adenocarcinoma
  <<First  <Prev  Next>  Last>>  Jump to